Recombinant Human C1 Esterase Inhibitor in the Prevention of Contrast-induced Nephropathy in High-risk Subjects

NCT02869347 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Acute Kidney Injury

Interventions

DRUG: Conestat alfa
DRUG: Sodium chloride 0.9%

Sponsor

University Hospital, Basel, Switzerland

Collaborators

[object Object]
[object Object]